Hepar Stannum 17/20 (Uriel Pharmacy Inc.)


Welcome to the PulseAid listing for the Hepar Stannum 17/20 drug offered from Uriel Pharmacy Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Uriel Pharmacy Inc.
NON-PROPRIETARY NAME: Hepar Stannum 17/20
SUBSTANCE NAME: MAMMAL LIVER; TIN
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00


Hepar Stannum 17/20 HUMAN OTC DRUG Details:

Item DescriptionHepar Stannum 17/20 from Uriel Pharmacy Inc.
LABELER NAME: Uriel Pharmacy Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 17; 20([hp_X]/1; [hp_X]/1)
START MARKETING DATE: 2009-09-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 48951-5046_576db6ba-c287-ebde-e053-2a91aa0aab51
PRODUCT NDC: 48951-5046
APPLICATION NUMBER:

Other MAMMAL LIVER; TIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Uriel Pharmacy Inc.Hepar Stannum 17/20